Valley Heart & Vascular Institute - Home

Meet Our Doctors

Meet Our Doctors We built our Heart and Vascular Institute on the expertise of dozens of board-certified cardiologists and surgeons. Please use the directory below to find a doctor affiliated with the Heart and Vascular Institute, or call us anytime at 201-447-8456.
Find a Physician:

Conditions We Treat

Conditions We Treat From atrial fibrillation to Wolff-Parkinson-White syndrome and every diagnosis in between, we will care for you like no other hospital. It´s the advanced cardiac care you need – when and where you need it most. Please click below for an overview of the conditions we treat. If you would prefer to speak with us, please call 201-447-8456.

View an A – Z listing of the conditions we treat

Treatments & Procedures

We treat virtually every type of cardiac and vascular diagnosis. Our network of board-certified cardiologists and surgeons is dedicated to providing you with the highest level of specialized care. Please click below for an overview of the treatments and procedures we provide. If you would prefer to speak with us, please call 201-447-8456.

View an A – Z listing of the treatments and procedures we perform
Treatments and Procedures


Clinical Trials
  • Accelerate
    The purpose of this study is the Assessment of Clinical Effects of Cholerstyl Ester Transfer Protein Inhibition with Evacetrapid in Patients at a High-Risk for Vascular Outcomes.
  • Cantos
    The purpose of this study is a randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP.
  • Odyssey
    The purpose of this study is A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome.
  • Vest
    The purpose of this study is a Vest prevention of Early Sudden Death Trial PREDiction of ICD Treatment Study.
    The purpose of this study is a Clinical Evaluation of the Absorb™ Bioresorbable Vascular Scaffold (BVS) in the Treatment of Subjects with de novo Native Coronary Artery Lesions.
  • Excel
    The purpose of this study is the Evaluation of XIENCE PRIME™ or XIENCE V® versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
  • Glagov (Amgen)
    A Randomized, Multi-Center, Placebo-Controlled, Parallel Group Study to Determine the Effects of AMG 145 Treatment on Atherosclerotic Disease Burden
  • Pioneer
    An Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
    Post-Approval Study Protocol of the St. Jude Medical Biocor™ and Biocor™ Supra Valve
  • B.U.T.S.
    Collection of Blood, Urine, and Tissue Specimens to Study Cardiovascular Disease
  • Cardiac Surgery Tissue Banking
    The purpose of this research is to obtain some of the excess tissue that is left over from surgeries for future research. We also will collect two 10ml vials of blood for use in future research.
  • MST
    Mechanical Strength Testing of Aortic Aneurysm Tissue The purpose of this study is to test the strength of aneurysm tissue after it has been replaced during surgery.
  • Secret CHF
    A Randomized, Double-Blind, Placebo controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure with Challenging Volume Management.
    This study is to learn if IDENTIFY-HF Risk Status Algorithm that uses information from the Reveal® insertable cardiac monitor calculates a heart failure risk status is able to predict the risk of a patient for going to the hospital for their heart condition.
    The purpose of this clinical study is to test the safety and effectiveness of the Medtronic Attain Performa quadripolar, left ventricular pacing lead.
    To determine, via continuous monitoring with the Reveal XT implantable cardiac monitor (ICM) or newer approved version (referred to as Reveal ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients once AF has been detected.
    The aim of this study is to evaluate the safety of the PARADYM RF SonR CRT-D device and SonRtip lead. Furthermore, to evaluate the effectiveness of the SonR optimization feature built into the device as compared to optimizing with echocardiography, which is the current clinical practice.
  • RAID
    To see how effective a drug called ranolazine is in reducing the risk of fast cardiac arrhythmias and death in people with ICDs.
    To evaluate the safety of Rivaroxaban and uninterrupted Vitamin K Antagonists (VKA) in adult subjects with NonValvular Atrial Fibrillation (NVAF) who undergo catheter ablation as measured by post-procedure major bleeding events.
    The CABANA trial is designed to test whether the treatment strategy of left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) will be superior to current rate control or rhythm control drugs for reducing total mortality in patients with untreated or incompletely treated AF.
  • Gloria
    The purpose of this study is a Global Registry on Long-Term Oral Anti-thrombotic Treatment in Patients with Atrial Fibrillation (Phase II/III)
  • Ischemia
    The purpose of this study is an International Study of Comparative Health Effectiveness with Medical and Invasive Approaches.
  • Penumbra 3D
    The purpose of this study is a randomized, concurrent controlled trial to assess the safety and effectiveness of the Separator 3D as a component of the Penumbra System in the revascularization of large vessel occlusion in acute ischemic stroke
  • Therapy
    The purpose of this study is The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke
  • Ace
    The purpose of this study is An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System.

Copyright © 2016 Valley Health System. All rights reserved.